Granules India Limited Fexofenadine Export Data — India (DGFT 2022–2026)

Name: Granules India Limited Fexofenadine Export Records India — #1 Exporter, 194 Shipments, $9.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fexofenadine

India Pharmaceutical Trade Intelligence

$109.6M224 Suppliers97 CountriesHS 30049039

ExportsIndia → UNITED KINGDOM30.8%India → UNITED STATES26.9%

ImportsSINGAPORE → India$150.2K BRAZIL → India$14.3K

#1 Supplier: GRANULES INDIA

Granules India Limited — Fexofenadine Exporter #1 | $9.7M Trade Value | TransData Nexus | TransData Nexus

Granules India Limited — Fexofenadine Exporter Profile

Indian Pharmaceutical Exporter · #1 for Fexofenadine · $9.7M export value · DGFT Verified

Granules India Limited is the #1 Indian exporter of Fexofenadine with $9.7M in export value and 194 verified shipments. Granules India Limited holds a 8.8% market share in Fexofenadine exports across 1 countries. The company exports 20 pharmaceutical products worth $412.3M across 9 therapeutic categories.

Granules India Limited — Fexofenadine Export Profile: Buyers & Destinations

Granules India Limited Fexofenadine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Fexofenadine?

Country	Value	Shipments	Share
UNITED KINGDOM	$33.8M	794	37.7%
UNITED STATES	$17.3M	345	19.2%
IRELAND	$11.0M	373	12.2%
AUSTRALIA	$8.8M	504

Who Are the Top Buyers of Fexofenadine from India?

Buyer	Country	Value	Orders
CHANELLE MEDICAL	IRELAND	$10.5M	358
MOVIANTO UK LTD	UNITED KINGDOM	$9.2M	184
MOVIANTO UK LIMITED	UNITED KINGDOM	$4.5M	90
ALLOGA UK LTD	UNITED KINGDOM	$4.3M	227
H.ESSERS & ZONEN INTERNATIONAL TRAN	BELGIUM	$4.2M	166
GRANULES CONSUMER HEALTH	UNITED STATES	$3.9M	78
GRANULES USA INC	UNITED STATES	$3.5M	71
NOUMED PHARMACEUTICALS PTY LTD	AUSTRALIA	$2.8M	247
GRANULES USA INC.	UNITED STATES	$1.8M	36
NOUMED LIFE SCINCES LIMITED	UNITED KINGDOM	$1.8M	36

India's Fexofenadine is purchased by 599 buyers worldwide. The top buyer is CHANELLE MEDICAL (IRELAND), followed by MOVIANTO UK LTD and MOVIANTO UK LIMITED.

How Does Granules India Limited Compare to Nearest Fexofenadine Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	CIPLA LIMITED	$13.6M	921	7	$14.8K
4	DR.REDDY'S LABORATORIES LTD	$12.4M	249	5	$50.0K
1	GRANULES INDIA LIMITED ★	$9.7M	194	1	$50.0K
5	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$7.7M	154	7	$50.0K
7	MEDREICH LIMITED	$5.7M	163	6	$34.8K

Granules India Limited ranks #1 among 224 Indian Fexofenadine exporters. Average shipment value of $50.0K compared to the market average of $365.5K. The closest competitors by value are CIPLA LIMITED and DR.REDDY'S LABORATORIES LTD.

Which Indian Ports Ship Fexofenadine Exports?

Port	Shipments	% Share
SAHAR AIR	569	13.4%
JNPT/ NHAVA SHEVA SEA	385	9.1%
SAHAR AIR CARGO ACC (INBOM4)	362	8.5%
NHAVA SHEVA SEA (INNSA1)	350	8.3%
HYDERABAD ICD	229	5.4%
CHAWAPAYAL ICD	186	4.4%
JNPT	161	3.8%
CHAWAPAYAL ICD (INCPR6)	142	3.4%

Geopolitical & Trade Policy Impact on Granules India Limited's Fexofenadine Exports

Granules India's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, compelling maritime carriers to reroute via the Cape of Good Hope. This has resulted in increased lead times and freight costs, posing challenges for time-sensitive pharmaceutical shipments. To mitigate these risks, Granules India is leveraging its multi-site manufacturing capabilities and strategic inventory positioning. (pharmaceuticalcommerce.com)

The U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters like Granules India, as global buyers seek to diversify their supply chains. However, compliance with evolving U.S. pharmaceutical import policies remains crucial. In the European Union, the implementation of the Falsified Medicines Directive necessitates stringent serialization and traceability measures. Granules India's proactive approach to regulatory compliance positions it favorably to navigate these complexities and maintain its export momentum.

Granules India Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Granules India, given its extensive export operations. The company's Gagillapur facility in Telangana received a warning letter from the U.S. Food and Drug Administration (FDA) in February 2025, following an inspection that identified issues related to equipment maintenance and contamination control. In response, Granules India implemented comprehensive corrective and preventive actions, including engaging independent consultants and enhancing cleaning protocols. The company has been providing regular updates to the FDA and is prepared for re-inspection to demonstrate compliance. (moneycontrol.com)

Conversely, Granules India's U.S.-based packaging facility in Virginia successfully cleared an FDA inspection in December 2025 with zero observations, reflecting the company's commitment to quality and regulatory excellence. (pharma.economictimes.indiatimes.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fexofenadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Granules India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 97+ countries, 599+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fexofenadine

Fexofenadine

Granules India Limited — Fexofenadine Exporter Profile

Granules India Limited — Fexofenadine Export Profile: Buyers & Destinations

Where Does India Export Fexofenadine?

Who Are the Top Buyers of Fexofenadine from India?

What Is India's Total Fexofenadine Export Value and How Much Does Granules India Limited Contribute?

What Is the Average Shipment Value for Granules India Limited's Fexofenadine Exports?

How Does Granules India Limited Compare to Other Indian Fexofenadine Exporters?

Regulatory Requirements: Exporting Fexofenadine to Key Markets

United Kingdom — MHRA

United States — FDA

How Does Granules India Limited Compare to Nearest Fexofenadine Exporters?

Which Indian Ports Ship Fexofenadine Exports?

What Other Antihistamines & Allergy Products Does Granules India Limited Export?

Geopolitical & Trade Policy Impact on Granules India Limited's Fexofenadine Exports

Granules India Limited — Regulatory Compliance & Quality Standards

About Granules India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fexofenadine Export Data from Granules India Limited

Fexofenadine Stats

Company Overview

Top Products by Granules India Limited

Related Analysis

Need Detailed Export Data?

Data Source